Spotlight
Video

ASCO 2013 - Phase II study of selumetinib (sel) versus temozolomide (TMZ) in gnaq/Gna11 (Gq/11) mutant (mut) uveal melanoma (UM) - Dr. Richard Carvajal

Loading........
Description: For more updates visit www.oncologyeducation.com....

Video interview with Dr. Richard Carvajal Phase II study of selumetinib (sel) versus temozolomide (TMZ) in gnaq/Gna11 (Gq/11) mutant (mut) uveal melanoma (UM) at ASCO 2013.
Shared By : oncologyeducation
Posted on : 06/23/13
Added : 4 years ago



More From oncologyeducation

Nothing found.